Sandoz is seeking an injunction to prevent Amgen from using certain patent rights to block biosimilar competition and allow Sandoz to launch Erelzi® as soon as possible. The company is also seeking ...

“The guideline authors have given us a solid, transparent and interpretable foundation on which we can begin to advocate and educate toward establishing a new standard of obesity care for children and ...

EDMONTON, Alberta, April 14, 2025 (GLOBE NEWSWIRE) -- Healthcare providers and families have a new roadmap to support collaborative, fully-informed, evidence-based care for children and adolescents ...

Approval based on Phase III STARGLO study where Columvi in combination with chemotherapy showed a 41% reduction in the risk of death compared to MabThera/Rituxan plus chemotherapy1,2 DLBCL is an ...

CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases. New Technology Add-on Payment (NTAP) Included in Proposed Fiscal ...

Lipozem reviews on Reddit present a mixed yet informative perspective on this natural weight loss supplement. Users ...

PrimeBiome is a gut-focused supplement formulated to help improve skin clarity, support healthier digestion, and foster an ...

Pursuant to the New OTBC Service Agreement, OTBC will be paid $100,000 in cash, which shall be payable in quarterly installments over 12 months, and receive an option pursuant to the Company’s stock ...

Dr. Aljurf is the first recipient from outside the United States, underscoring his global impact on hematopoietic stem cell ...

This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders, today ...